Chemical Compound
(6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt; Cefotax; HR 756; Pretor; Tolycar; Cefotaxime sodium; Sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
CAS Registry Number
64485-93-4
Primary record
(6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt; Cefotax; HR 756; Pretor; Tolycar; Cefotaxime sodium; Sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 库存
- 4,195 克
- 纯度
- 99.0 %
- CAS
- 64485-93-4
化合物标识与属性
- CAS
- 64485-93-4
- PubChem CID
- 10695961
- SMILES
- CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]
- Canonical SMILES
- CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(COC(C)=O)CS[C@H]12)c1csc(N)n1.[Na+]
名称与同义词
- CEFOTAXIME SODIUM
- Sodium cefotaxime
- Claforan
- Pretor
- CEFOTAXIME SODIUM SALT
- Tolycar
- Cefotax
- cefotaxime
- Ralopar
- Tolycor
- Zariviz
- Claforan sodium
- 64485-93-4
- Ceftoringe
- Califrid
- Cefacron
- Cefantral
- Cefomerc
- Cefronate
- Epotazime
- Evotaxime
- Oritaxim
- Zafixime
- Cefomed
- Cefotam
- Cefoxim
- Chemcef
- Clafora
- Claftax
- Eaxiron
- Elkotak
- Novatax
- Sefagen
- Biolog
- Biotax
- Bioxim
- Calcef
- Cefcan
- Cefcil
- Ceftim
- Ceftop
- Clavox
- Fortax
- Baxim
- Cefon
- Cefotaximesodium
- Excef
- Forax
- Cefotaxim sodium
- CefSo
- (+)-Cefotaxime sodium salt
- Cefotaxime (sodium)
- Sodium, Cefotaxime
- cefotaxime injection
- Claforan (TN)
- Prestwick_823
- Cefotaxim sodium salt
- Cefotaxime sodium CRS
- RefChem:54735
- C16H16N5NaO7S2
- HR 756
- Cefotaxime (sodium salt)
- Opera_ID_1945
- DTXSID4046991
- UNII-258J72S7TZ
- MLS000028559
- Cefotaxime Sodium (sterile)
- CHEBI:3498
- 258J72S7TZ
- CHEMBL1010
- HR756
- HR-756
- SCHEMBL41092
- MSK10011Na
- MLS001077352
- MLS001333684
- MLS002222330
- Sym-methoxyimino Cephalosporin
- Cefotaxime sodium salt (syn-isomer)
- RU 24756
- C16H17N5O7S2.Na
- MFCD00079073
- Ru-24756
- Cefotaxime sodium [USAN:JAN]
- DTXCID201476109
- orb1310177
- orb3025809
- Cefotaxime (sodium) (Standard)
- CEFOTAXIME SODIUM [JAN]
- Cefotaxime sodium (JP18/USP)
- CEFOTAXIME SODIUM [USAN]
- NSC-756666
- Cefotaxime sodium [USAN:USP:JAN]
- EINECS 264-915-9
- ERK5-1A08
- HY-A0088R
- Cefotaxime sodium [EP monograph]
- CEFOTAXIME SODIUM [VANDF]
- Cefotaxime for peak identification
- Cefotaxime sodium - Sterile grade
- CEFOTAXIME SODIUM [MART.]
- HMS1568K20
- HMS2095K20
- HMS2233J21
- HMS3260H18
- HMS3712K20
- CEFOTAXIME SODIUM [USP-RS]
- CEFOTAXIME SODIUM [WHO-DD]
- Ru24756
- AMY40166
- CEFOTAXIME SODIUM SALT [MI]
- HY-A0088
- Tox21_110791
- Tox21_500278
- NP3235
- s4517
- SMR000058812
- AKOS015951272
- C16-H16-N5-O7-S2.Na
- Cefotaxime for peak identification CRS
- AC11346
- CCG-220139
- CCG-221582
- CEFOTAXIME SODIUM [EP IMPURITY]
- CEFOTAXIME SODIUM [ORANGE BOOK]
- CID5702018
- CS-4297
- KS-1416
- NSC 756666
- CEFOTAXIME SODIUM [USP IMPURITY]
- CID10695961
- CEFOTAXIME SODIUM [USP MONOGRAPH]
- NCGC00017128-01
- NCGC00093734-01
- NCGC00093734-02
- NCGC00260963-01
- AC165016
- AN-38760
- Cefotaxime and dextrose 2.4% in plastic container
- Cefotaxime and dextrose 3.9% in plastic container
- K035
- SMR000653480
- SMR001307269
- AB1009356
- CAS-64485-93-4
- Cefotaxime sodium salt, 97% - 25G 25g
- CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
- ethyl 3-oxo-2-propan-2-yloxyiminobutanoate
- N-(tert-butyliminomethyl)-N-methylacetamide
- C2224
- CEFOTAXIME SODIUM, REFERENCE STANDARD
- EU-0100278
- A16005
- C 7912
- C08113
- D00919
- F90396
- J10142
- Sodium 7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)cephalosporanate
- CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
- EN300-25953723
- 64485-93-4, 63527-52-6 [cefotaxime]
- A1204536
- Cefotaxime sodium salt, potency: 916-964 mug per mg
- Q27106109
- sodium;(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 2-(4-chlorophenyl)-3-methyl-4,5,6,7-tetrahydroindazole
- sodium;(6R,7R)-3-(acetyloxymethyl)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Cefotaxime sodium, European Pharmacopoeia (EP) Reference Standard
- (6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, (6R,7R)-
- Cefotaxime sodium salt, plant cell culture tested, BioReagent, powder
- Cefotaxime sodium, United States Pharmacopeia (USP) Reference Standard
- sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Sodium (6R,7R)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate 7(sup 2)-(Z)-(O-methyloxime), acetate (ester)
- Cefotaxime for peak identification, European Pharmacopoeia (EP) Reference Standard
- Cefotaxime sodium salt, 92%, a third-generation cephalosporin antibiotic - 25G 25g
- ([6R-[6alpha,7beta(z)]]-3-[(Acetyloxy)methyl]-[[(2-amine-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid monosodium salt
- (6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt; Cefotax; HR 756; Pretor; Tolycar; Cefotaxime sodium; Sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(Z)))-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, [6R-[6alpha,7beta(Z)]]-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-1-oxoethyl]amino]-8-oxo-,?sodium salt, (6R,7R)- (1:1)
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-, sodium salt (1:1), (6R,7R)-
- 64486-02-8
- 64486-25-5
- 64487-13-4
- CTX
- Monosodium (6R,7R)-3-acetoxymethyl-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetylamino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
- SODIUM (6R,7R)-3-(ACETOXYMETHYL)-7-((E)-2-(2-AMINOTHIAZOL-4-YL)-2-(METHOXYIMINO)ACETAMIDO)-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE
- sodium (6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium (6R,7R)-3-(acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Sodium (6R,7R)-3-[(acetyloxy)methyl]-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Sodium (6R-(6alpha,7beta(Z)))-3-(acetoxymethyl)-7-((2-aminothiazol-4-yl)(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
- Sodium [6R-[6alpha,7beta(Z)]]-3-(acetoxymethyl)-7-[(2-aminothiazol-4-yl)(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium 3-(acetoxymethyl)-7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3,4-didehydrocepham-4-carboxylate